143 related articles for article (PubMed ID: 18847451)
41. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines.
Fang MZ; Jin Z; Wang Y; Liao J; Yang GY; Wang LD; Yang CS
Int J Oncol; 2005 Mar; 26(3):615-22. PubMed ID: 15703815
[TBL] [Abstract][Full Text] [Related]
42. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
43. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.
Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X
Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536
[TBL] [Abstract][Full Text] [Related]
44. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
Dong SM; Kim HS; Rha SH; Sidransky D
Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
[TBL] [Abstract][Full Text] [Related]
45. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338
[TBL] [Abstract][Full Text] [Related]
46. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
[TBL] [Abstract][Full Text] [Related]
47. Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regions.
Sakai N; Kajiyama Y; Iwanuma Y; Tomita N; Amano T; Isayama F; Ouchi K; Tsurumaru M
Dis Esophagus; 2010 Jul; 23(5):415-21. PubMed ID: 19930403
[TBL] [Abstract][Full Text] [Related]
48. [Methylation quantification of adenomatous polyposis coli (APC) gene promoter in plasma of lung cancer patients].
Pan SY; Xie EF; Shu YQ; Gao L; Zhang LX; Chen D; Chen JB; Zhao WJ; Mu Y; Zhang JN
Ai Zheng; 2009 Apr; 28(4):384-9. PubMed ID: 19622298
[TBL] [Abstract][Full Text] [Related]
49. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K
Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676
[TBL] [Abstract][Full Text] [Related]
50. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
[TBL] [Abstract][Full Text] [Related]
51. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.
Zhao BJ; Sun DG; Zhang M; Tan SN; Ma X
Dis Esophagus; 2009; 22(1):55-61. PubMed ID: 18564167
[TBL] [Abstract][Full Text] [Related]
52. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
[TBL] [Abstract][Full Text] [Related]
53. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417
[TBL] [Abstract][Full Text] [Related]
54. Lymph node metastasis in squamous cell carcinoma of the intrathoracic esophagus.
Liu CC; Fahn HJ; Li WY; Wu YC; Huang MH; Wang LS
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Feb; 61(2):77-84. PubMed ID: 9532869
[TBL] [Abstract][Full Text] [Related]
55. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
Mandelker DL; Yamashita K; Tokumaru Y; Mimori K; Howard DL; Tanaka Y; Carvalho AL; Jiang WW; Park HL; Kim MS; Osada M; Mori M; Sidransky D
Cancer Res; 2005 Jun; 65(11):4963-8. PubMed ID: 15930319
[TBL] [Abstract][Full Text] [Related]
56. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.
Esteller M; Sparks A; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Gonzalez S; Tarafa G; Sidransky D; Meltzer SJ; Baylin SB; Herman JG
Cancer Res; 2000 Aug; 60(16):4366-71. PubMed ID: 10969779
[TBL] [Abstract][Full Text] [Related]
57. Monoallelic methylation of the APC promoter is altered in normal gastric mucosa associated with neoplastic lesions.
Clément G; Bosman FT; Fontolliet C; Benhattar J
Cancer Res; 2004 Oct; 64(19):6867-73. PubMed ID: 15466175
[TBL] [Abstract][Full Text] [Related]
58. Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
Yegnasubramanian S; Kowalski J; Gonzalgo ML; Zahurak M; Piantadosi S; Walsh PC; Bova GS; De Marzo AM; Isaacs WB; Nelson WG
Cancer Res; 2004 Mar; 64(6):1975-86. PubMed ID: 15026333
[TBL] [Abstract][Full Text] [Related]
59. Methylation status of retinoic acid receptor beta2 promoter and global DNA in esophageal squamous cell carcinoma.
Li RN; Yu FJ; Wu CC; Chen YK; Yu CC; Chou SH; Lee JY; Cheng YJ; Wu MT; Wu IC
J Surg Oncol; 2014 May; 109(6):623-7. PubMed ID: 24510455
[TBL] [Abstract][Full Text] [Related]
60. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
